The Anaphase Promoting Complex: A Critical Target for Viral Proteins and Anti-Cancer Drugs

 Abstract

The study of animal viruses has provided extraordinary insights into cell cycle dynamics and tumor biology. The significance of the p53 and Rb tumor suppressor proteins, for example, was discovered due to their interactions with viral oncogenes. In the past several years, investigations with four viral proteins, human immunodeficiency virus type 1 (HIV-1) vpr, adenovirus E4orf4, chicken anemia virus (CAV) apoptin and human T lymphotropic virus type I (HTLV-I) Tax, have indicated that there are also critical viral targets involved in G2/M control. In particular, recent studies with E4orf4 and apoptin have shown that they induce G2/M arrest by targeting and inhibiting the anaphase-promoting complex/cyclosome (APC/C). Notably, these two viral proteins induce apoptosis selectively in transformed cells in a p53-independent manner; thus pathways affected by these proteins are of significant therapeutic interest. Further investigation of the underlying mechanism of G2/M arrest and subsequent apoptosis induced by viral APC/C inhibitors may shed light on the mechanisms of current cancer therapies and provide the foundation for developing novel therapeutic targets.

Full Text Options
Article
Metrics
 Share
 Info
Pages
557 - 560
doi
10.4161/cc.4.4.1606
Type
Perspectives
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
The Anaphase Promoting Complex: A Critical Target for Viral Proteins and Anti-Cancer Drugs